SPR Therapeutics: Peripheral Nerve Stimulation To Treat Pain
Executive Summary
The Smartpatch from SPR Therapeutics LLC stimulates the peripheral nerves that carry the pain signal to the central nervous system. The minimally invasive and reversible neurostimulation system can remain implanted for up to 60 days, offering therapy to patients in acute as well as chronic pain.
You may also be interested in...
Market Intel: Peripheral Nerve Stim Players Edge Out Innovative Paths
While demand for spinal cord stimulation (SCS) devices used in pain management continues to expand at double-digit rates, a small but growing number of highly innovative companies that develop stimulators to specifically target peripheral nerve pain is creating excitement among pain doctors looking for better options to treat an intractable population that's seen little success with standard therapy. With millions of people worldwide suffering from low back pain, severe headaches and migraines, neck pain and other chronic pain, the demand for safe, effective, percutaneously-placed devices remains high. In this article, we'll highlight emerging companies working on PNS devices and provide insights from pain physicians on the pros and cons of these devices.
Still Can’t Cancel That Gym Membership? FTC Proposes One Negative Option Rule To Rule Them All
The FTC published a notice of proposed rulemaking on 23 March to update its 1973 Negative Option Rule, which has become obsolete vis-à-vis new marketing strategies in today’s digital world. Proposed amendments would clarify, expand and consolidate negative option-related provisions currently dispersed across different FTC laws and regulations.
What’s Next? Five Things To Look Out For In April
Generics Bulletin previews the biggest events and changes for industry in the coming month.